Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3

Natural killer (NK) cells, a key member of innate lymphocytes, are a promising immunotherapeutic target for ischemic stroke. Astragaloside IV (ASIV) is isolated from Astragalus mongholicus Bunge (Fabaceae), a herbal medicine possessing immunomodulatory ability. This study investigated the effect of...

Full description

Bibliographic Details
Main Authors: Shichun Li, Baokai Dou, Shi Shu, Luyao Wei, Shiguo Zhu, Zunji Ke, Zhifei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.802047/full
_version_ 1798030124763840512
author Shichun Li
Shichun Li
Baokai Dou
Shi Shu
Luyao Wei
Shiguo Zhu
Zunji Ke
Zhifei Wang
author_facet Shichun Li
Shichun Li
Baokai Dou
Shi Shu
Luyao Wei
Shiguo Zhu
Zunji Ke
Zhifei Wang
author_sort Shichun Li
collection DOAJ
description Natural killer (NK) cells, a key member of innate lymphocytes, are a promising immunotherapeutic target for ischemic stroke. Astragaloside IV (ASIV) is isolated from Astragalus mongholicus Bunge (Fabaceae), a herbal medicine possessing immunomodulatory ability. This study investigated the effect of ASIV on NK cells during the acute stage of brain ischemic injury in a mouse model of middle cerebral artery occlusion (MCAO). MCAO mice treated with ASIV had better functional outcomes, smaller brain infarction and less NK cell brain infiltration. NK cell depletion echoed the protective effect of ASIV. Notably, ASIV did not enhance the protective effect of NK cell depletion against brain ischemic injury. ASIV inhibited glial cell-derived CCL2-mediated chemotaxis to prevent post-ischemic NK cell brain recruitment. Meanwhile, ASIV also abrogated NK cell-mediated cytolytic killing of neurons subjected to oxygen-glucose deprivation and suppressed NK cell-derived IFN-γ and NKG2D expression in the ischemic brain. The inhibitory effect of ASIV on NK cell brain infiltration and activation was mimicked by cryptotanshinone, a STAT3 inhibitor. There was no additive effect when ASIV and cryptotanshinone were used together. In conclusion, ASIV inhibits post-ischemic brain infiltration and activation of NK cells through STAT3 suppression, and this inhibitory effect of ASIV on NK cells plays a key role in its protection against acute ischemic brain injury. Our findings suggest that ASIV is a promising therapeutic candidate in NK cell-based immunotherapy for the treatment of acute ischemic stroke and pave the way for potential clinical trials.
first_indexed 2024-04-11T19:35:09Z
format Article
id doaj.art-71e376cd4c2c49ddb6294602312e57ee
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T19:35:09Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-71e376cd4c2c49ddb6294602312e57ee2022-12-22T04:06:52ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-02-011210.3389/fphar.2021.802047802047Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3Shichun Li0Shichun Li1Baokai Dou2Shi Shu3Luyao Wei4Shiguo Zhu5Zunji Ke6Zhifei Wang7School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaAcademy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaAcademy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaAcademy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaNatural killer (NK) cells, a key member of innate lymphocytes, are a promising immunotherapeutic target for ischemic stroke. Astragaloside IV (ASIV) is isolated from Astragalus mongholicus Bunge (Fabaceae), a herbal medicine possessing immunomodulatory ability. This study investigated the effect of ASIV on NK cells during the acute stage of brain ischemic injury in a mouse model of middle cerebral artery occlusion (MCAO). MCAO mice treated with ASIV had better functional outcomes, smaller brain infarction and less NK cell brain infiltration. NK cell depletion echoed the protective effect of ASIV. Notably, ASIV did not enhance the protective effect of NK cell depletion against brain ischemic injury. ASIV inhibited glial cell-derived CCL2-mediated chemotaxis to prevent post-ischemic NK cell brain recruitment. Meanwhile, ASIV also abrogated NK cell-mediated cytolytic killing of neurons subjected to oxygen-glucose deprivation and suppressed NK cell-derived IFN-γ and NKG2D expression in the ischemic brain. The inhibitory effect of ASIV on NK cell brain infiltration and activation was mimicked by cryptotanshinone, a STAT3 inhibitor. There was no additive effect when ASIV and cryptotanshinone were used together. In conclusion, ASIV inhibits post-ischemic brain infiltration and activation of NK cells through STAT3 suppression, and this inhibitory effect of ASIV on NK cells plays a key role in its protection against acute ischemic brain injury. Our findings suggest that ASIV is a promising therapeutic candidate in NK cell-based immunotherapy for the treatment of acute ischemic stroke and pave the way for potential clinical trials.https://www.frontiersin.org/articles/10.3389/fphar.2021.802047/fullnatural killer cellsbrain ischemiaastragaloside IVoxygen-glucose deprivationsignal transducer and activator of transcription 3
spellingShingle Shichun Li
Shichun Li
Baokai Dou
Shi Shu
Luyao Wei
Shiguo Zhu
Zunji Ke
Zhifei Wang
Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3
Frontiers in Pharmacology
natural killer cells
brain ischemia
astragaloside IV
oxygen-glucose deprivation
signal transducer and activator of transcription 3
title Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3
title_full Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3
title_fullStr Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3
title_full_unstemmed Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3
title_short Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Via Inhibiting STAT3
title_sort suppressing nk cells by astragaloside iv protects against acute ischemic stroke in mice via inhibiting stat3
topic natural killer cells
brain ischemia
astragaloside IV
oxygen-glucose deprivation
signal transducer and activator of transcription 3
url https://www.frontiersin.org/articles/10.3389/fphar.2021.802047/full
work_keys_str_mv AT shichunli suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT shichunli suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT baokaidou suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT shishu suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT luyaowei suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT shiguozhu suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT zunjike suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3
AT zhifeiwang suppressingnkcellsbyastragalosideivprotectsagainstacuteischemicstrokeinmiceviainhibitingstat3